Economic value of influenza vaccination

Chiara Cadeddu, Maria Lucia Specchia, Walter Ricciardi, Chiara De Waure, Maria Assunta Veneziano, Silvio Capizzi, Stefano Capri

Risultato della ricerca: Contributo in rivistaArticolo in rivista

17 Citazioni (Scopus)


Influenza epidemics are responsible for high mortality and morbidity rates in particular among elderly and high risk groups. This review is aimed at assessing the economic value of vaccination in these groups. A search of full economic evaluations of influenza vaccination in comparison with no interventions was performed on PubMed from January 1990 to May 2011. Only economic evaluations dealing with elderly and high risk groups were considered. The quality of selected articles was assessed through Drummond's checklist. Sixteen cost-effectiveness analyses and four cost-benefit analyses were included: overall, the quality of studies was fairly good. The vaccination was demonstrated to be cost-effective or cost-saving in almost all studies, independently by the perspective and the type of analysis. Influenza vaccination is a worthwhile intervention from the pharmacoeconomic view-point, anyway a standardization of methods should be desirable in order to guarantee the comparability and transferability of results.
Lingua originaleEnglish
pagine (da-a)119-129
Numero di pagine11
Stato di pubblicazionePubblicato - 2012


  • Economic evaluation
  • Influenza
  • Vaccine


Entra nei temi di ricerca di 'Economic value of influenza vaccination'. Insieme formano una fingerprint unica.

Cita questo